Immune Tolerance: High-Dose Regimen

Inhibitors in Patients with Haemophilia

Volumn , Issue , 2008, Pages 45-48

  Brackmann, H H ^a   Wallny, T ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Bonn protocol; High dose regimen; Immune tolerance; Immune tolerance induction; Side effects

Indexed keywords

EID: 84949470041     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470757260.ch7     Document Type: Chapter

References (16)

1. Brackmann HH, Gormsen J. Massive factor VIII infusion in a haemophiliac with factor VIII inhibitor, high response. Lancet 1977; 2: 933.
2. Oldenburg J, Schwaab R, Brackmann H-H. Induction of immune tolerance in haemophilia A, inhibitor patients by the 'Bonn Protocol':predictive parameter for therapy duration and outcome. Vox Sang 1999; 77 (Suppl. 1): 49-54.
3. Ewing N, Sanders NL, Dietrich SL, Kasper CK. Induction of immune tolerance to factor VII in hemophiliacs. JAMA 1988; 259:65-8.
4. van Leewen EF, Mauser-Bunschoten EP, van Dijken PJ, Kok AJ, Sjamsedin-Visset EJM, Sixma JJ.Disappearance factor VIII. C antibodies in patients with haemophilia A upon frequent administration of factor VIII in intermediate or low dose. Br J Haematol 1986; 64: 291-7.
5. Manno CS. Treatment options for bleeding episodes in patients undergoing immune tolerance therapy. Haemophilia 1999; 5 (Suppl. 3): 33-41.
6. Brackmann HH, Lenk H, Scharrer I, Auerswald G, Kreuz W. German recommendations for immune tolerance therapy in type A haemophiliacs with antibodies. Haemophilia 1999; 5: 203-6.
7. Scheibel E, Ingerslev J, Dalsgaard-Nielsen J, Stenberg S, Knudson JB, and the Danish study group. Continuous high-dose factor VIII for the induction of immune tolerance in haemophilia A patients with high responder state: a description of eleven patients treated. Thromb Haemost 1987; 58: 1049-52.
8. White GC, Roberts HR. The treatment of factor VIII inhibitorsaa general overview. Vox Sang 1996; 70 (Suppl. 1): 19-23.
9. Kurczinsky EM, Penner JA. Activated prothrombin concentrate for patients with factor VIII inhibitors. N Engl J Med 1974; 291:164-7.
10. Brackmann HH, Oldenburg J, Schwaab R. Immune tolerance for the treatment of factor VIII inhibitorsatwenty years 'Bonn Protocol'. Vox Sang 1996; 70 (Suppl. 1): 30-5.
11. Mariani G, Ghirardini A, Bellocco R.Immune tolerance in hemophiliaaprincipal results from the international registry. Report of the factor VIII and IX subcommittee. Thromb Haemost 1994; 72: 155-8.
12. Brackmann HH. Successful treatment of hemophilia A inhibitor patients with induced immunotolerance. In: Proceedings of the 4th International Symposium on Hemophilia Treatment. Tokyo 1984:187-96.
13. Brackmann HH. Induction of Immune tolerance in hemophiliacs with inhibitors to factor VIII and IX. XIIth Congress of the International Society on Thrombosis and Haemostasis, Kyoto 1989.
14. Scharrer I, Neutzling O. Incidence of inhibitors in haemophiliacs. A review of the literature. Blood Coag Fibrinol 1993; 4: 753-8.
15. Brackmann H-H, Schwaab R, Effenberger W, Hess L, Hanfland P, Oldenburg J. Side effects during immune tolerance induction. Haematologica 2000; 85 (Suppl. 10): 75-7.
16. Leitlinien Bundesärztekammer (Guidelines of the German Medical Association). www.bundesaerztekammer.de.